LPL Financial’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-60,735
Closed -$6.17M 6042
2025
Q4
$6.17M Sell
60,735
-14,990
-20% -$1.2M ﹤0.01% 2360
2025
Q3
$4.14M Buy
75,725
+12,265
+19% +$613K ﹤0.01% 2644
2025
Q2
$3.37M Buy
63,460
+1,090
+2% +$55.4K ﹤0.01% 2631
2025
Q1
$2.7M Sell
62,370
-15,323
-20% -$776K ﹤0.01% 2680
2024
Q4
$4.37M Sell
77,693
-3,004
-4% -$187K ﹤0.01% 2194
2024
Q3
$5.5M Buy
80,697
+1,506
+2% +$85K ﹤0.01% 1916
2024
Q2
$3.35M Sell
79,191
-844
-1% -$46.4K ﹤0.01% 2170
2024
Q1
$5.53M Sell
80,035
-4,689
-6% -$297K ﹤0.01% 1698
2023
Q4
$6.27M Buy
84,724
+4,548
+6% +$298K ﹤0.01% 1542
2023
Q3
$5.47M Buy
80,176
+3,040
+4% +$258K ﹤0.01% 1552
2023
Q2
$7.24M Sell
77,136
-5,473
-7% -$427K 0.01% 1339
2023
Q1
$5.6M Buy
82,609
+3,289
+4% +$211K ﹤0.01% 1433
2022
Q4
$3.93M Sell
79,320
-4,797
-6% -$196K ﹤0.01% 1607
2022
Q3
$2.73M Sell
84,117
-1,529
-2% -$63K ﹤0.01% 1770
2022
Q2
$3.37M Sell
85,646
-7,995
-9% -$428K ﹤0.01% 1648
2022
Q1
$6.55M Sell
93,641
-17,026
-15% -$1.24M 0.01% 1279
2021
Q4
$8.61M Buy
110,667
+5,816
+6% +$513K 0.01% 1108
2021
Q3
$10M Sell
104,851
-2,516
-2% -$266K 0.01% 971
2021
Q2
$13.3M Buy
107,367
+6,871
+7% +$820K 0.01% 766
2021
Q1
$13.2M Sell
100,496
-363
-0.4% -$49.7K 0.02% 702
2020
Q4
$13.4M Buy
100,859
+1,040
+1% +$126K 0.02% 618
2020
Q3
$10.2M Sell
99,819
-9,000
-8% -$777K 0.02% 636
2020
Q2
$9.46M Buy
108,819
+12,438
+13% +$994K 0.02% 606
2020
Q1
$5.59M Sell
96,381
-6,231
-6% -$506K 0.01% 704
2019
Q4
$9.49M Buy
102,612
+18,191
+22% +$1.6M 0.02% 594
2019
Q3
$7.63M Buy
84,421
+145
+0.2% +$16.5K 0.02% 631
2019
Q2
$9.95M Buy
84,276
+3,960
+5% +$399K 0.02% 505
2019
Q1
$6.96M Buy
80,316
+18,568
+30% +$1.58M 0.02% 630
2018
Q4
$3.9M Buy
61,748
+12,950
+27% +$889K 0.01% 796
2018
Q3
$3.85M Buy
48,798
+3,437
+8% +$224K 0.01% 854
2018
Q2
$2.71M Sell
45,361
-4,072
-8% -$219K 0.01% 962
2018
Q1
$1.99M Buy
49,433
+13,323
+37% +$650K 0.01% 1120
2017
Q4
$1.9M Buy
36,110
+311
+0.9% +$16.6K 0.01% 1102
2017
Q3
$1.69M Sell
35,799
-2,761
-7% -$111K 0.01% 1087
2017
Q2
$1.36M Buy
+38,560
New +$1.19M 0.01% 1172
2016
Q3
Sell
-25,306
Closed -$314K 2669
2016
Q2
$314K Sell
25,306
-12,666
-33% -$95.4K ﹤0.01% 2030
2016
Q1
$272K Sell
37,972
-138
-0.4% -$883 ﹤0.01% 2586
2015
Q4
$324K Buy
38,110
+19,015
+100% +$177K ﹤0.01% 2480
2015
Q3
$354K Buy
19,095
+740
+4% +$17K ﹤0.01% 2071
2015
Q2
$518K Buy
18,355
+2,785
+18% +$70K ﹤0.01% 1875
2015
Q1
$338K Buy
15,570
+398
+3% +$10.1K ﹤0.01% 2142
2014
Q4
$416K Buy
15,172
+2,266
+18% +$55.1K ﹤0.01% 1906
2014
Q3
$242K Buy
12,906
+2,206
+21% +$40.4K ﹤0.01% 2322
2014
Q2
$182K Sell
10,700
-2,550
-19% -$35.1K ﹤0.01% 2513
2014
Q1
$188K Buy
13,250
+1,185
+10% +$16K ﹤0.01% 2465
2013
Q4
$142K Sell
12,065
-10,000
-45% -$115K ﹤0.01% 2517
2013
Q3
$224K Buy
22,065
+65
+0.3% +$834 ﹤0.01% 2233
2013
Q2
$306K Buy
+22,000
New +$239K ﹤0.01% 1895

Other funds holding EXAS

LPL Financial's EXAS Position: Q1 2026 in Review

LPL Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 60,735 shares — an estimated $6.17M sold.

LPL Financial first reported a position in EXAS in Q2 2013 and held it in 48 quarters. The position peaked at $13.4M in Q4 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • LPL Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 60,735 Exact Sciences shares in Q1 2026, an estimated $6.17M.
  • LPL Financial first reported a position in Exact Sciences in Q2 2013 and held it in 48 quarters.
  • LPL Financial's Exact Sciences position peaked at $13.4M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.